Professional Documents
Culture Documents
net/publication/326815057
CITATIONS READS
2 122
5 authors, including:
Saulius Vaitkus
Lithuanian University of Health Sciences
82 PUBLICATIONS 731 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Nora Siupsinskiene on 21 August 2018.
primary aim of this study was to determine the prevalence of Video rhinolaryngoscopy
H pylori infection in nasal biopsy specimens from patients
Clinical examination of the condition of the patient’s ear, nose,
with chronic rhinosinusitis with polyposis versus that in con-
throat and larynx was carried out using a specially designed
trol patients. The secondary aim was to assess the correlations
form. For all patients, diagnostic rhinolaryngoscopy was per-
between H pylori infection identified in nasal tissue and
formed in the out-patient department with a flexible 3.2 mm
patients’ sociodemographic data and reflux-related symptoms
endoscope (RLS; Kay Elemetrics, Lincoln Park, New Jersey,
and signs.
USA), according to standard protocol. The same examiner
used the same sterilised equipment for each patient.
Materials and methods A validated reflux finding score scale was used to determine
the presence of subglottic oedema, ventricular obliteration,
The study was performed at the Hospital of Lithuanian
erythema, vocal fold oedema, diffuse laryngeal oedema, pos-
University of Health Sciences, Kaunas, from January 2011 to
terior commissure hypertrophy, granuloma and thick endolar-
July 2012. A total of 45 adult patients (16 females and 29
yngeal mucus.13 A reflux finding score of more than 7 was
males), aged 18–85 years (with an average age (± standard
considered abnormal.13
deviation (SD)) of 51.8±14.9 years), who underwent endo-
The video recordings were rated by an observer, who was
scopic sinus surgery for chronic rhinosinusitis with nasal
unaware of the patient’s identity. The intra-rater correlation
polyposis, and agreed to participate in the study, were selected
for the video recordings (calculated over a 1-month time inter-
for inclusion in the clinical group. Patients were excluded from
val, using 10 patient video recordings randomly selected from
the study if: they were on antibiotics or proton pump inhibi-
the list) was 0.86.
tors (PPIs) four weeks prior to surgery; or they had antrochoa-
nal polyps, Samter’s triad, an immunological disorder, or
unilateral, allergic or fungal sinusitis. H pylori identification methods
All patients had received local steroid therapy for three
months, with no regression of the polyps. A diagnosis of H pylori infection was identified via a histochemical examin-
chronic rhinosinusitis with nasal polyposis was made on the ation and a rapid urease test. The samples were collected
basis of clinical examination (nasal symptoms and nasal from nasal polyps for the clinical group patients and from
endoscopy) and sinus computed tomography findings. Nasal nasal lateral wall mucosa for the control group patients,
biopsy samples were obtained during endoscopic sinus surgery using sterile instruments. A rapid urease test was performed
under general anaesthesia. at the beginning of nasal surgery according to the manufac-
The control group consisted of 30 patients (6 females and turer’s instructions. The biopsy samples were kept in paraffin
24 males), aged 19–78 years (average age (± SD) 41.6 ± 17.6 blocks until needed for the histological and histochemical
years), who were admitted to the hospital because of nasal sep- examinations.
tum deviation. The absence of nasal polyps was confirmed by Regarding the histochemical examination, the biopsy
nasal endoscopy. Nasal biopsy samples were collected from the material from the nasal tissues was subjected to Giemsa stain-
lateral nasal wall below the middle turbinate during septo- ing. Specifically, two 4-μm thick, paraffin-embedded sections
plasty. Only patients whose histological examinations of the were prepared and stained using the modified methodology
removed nasal mucosa revealed normal tissue were selected (H pylori acquires a dark blue colour) (Figure 1).14
for inclusion in the control group. Regarding the rapid urease test, at the beginning of surgery,
The study was conducted after receiving permission from the sterile bioptate (minimum 2 × 2 mm pieces) was placed
the Kaunas Regional Biomedical Research Ethics Committee into a medium with urea and a pH indicator. When the
(number P1-86/2011). Informed consent was obtained from material contained H pylori, the urease enzyme changed
all the patients investigated. the endogenous urea into ammonia and carbon dioxide.
Moreover, the pH was changed by the released ammonia, and
the indicator colour shifted from yellow to orange, red or purple.
Patient evaluation questionnaire The campylobacter-like organism test (Kimberly-Clark, New
Prior to surgery, all patients were required to complete a spe- Milford, Connecticut, USA) was used. The changes in colour
cially designed questionnaire. This assessed demographics, were evaluated after 20 minutes, and after 1 and 3 hours, as
unhealthy habits, and reflux-associated information including recommended.15 If the results of the two tests were positive,
their history of gastroesophageal reflux disease (regular use of H pylori was considered present in the biopsy material of the
PPIs reported in the anamnesis and/or reflux-related findings nasal tissues.
on upper gastrointestinal endoscopy).
Statistical analysis
Reflux-related symptoms
Statistical analysis was performed using SPSS software, version
These were assessed with a standardised, validated question- 17 for Windows (SPSS, Chicago, Illinois, USA). The differ-
naire and the reflux symptom index. The reflux symptom ences in qualitative parameters were calculated using the chi-
index examines nine symptoms common in laryngopharyn- square or Fisher’s exact tests. The unpaired student’s t-test
geal reflux: hoarseness; throat clearing; excess throat mucus; (two-tailed) was used to compare the differences between
difficulty in food swallowing; coughing after eating or after the quantitative data of the two groups. Analysis examining
lying down; choking episodes; troublesome cough; lump in the correlations between H pylori infection identified in the
the throat; and heartburn, chest pain, indigestion or regurgita- nasal tissue and different variables, such as demographics
tion.12 The symptoms were self-rated on a six-point scale from (age, gender, body mass index), unhealthy habits (alcohol
0 (not a problem) to 5 (a severe problem). A reflux symptom consumption, smoking), a history of gastroesophageal reflux
index of 13 points or more was considered abnormal.12 disease, reflux-related symptoms (assessed by the reflux
Downloaded from https://www.cambridge.org/core. IP address: 78.63.210.201, on 04 Aug 2018 at 12:43:07, subject to the Cambridge Core terms of use, available at
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0022215118001299
The Journal of Laryngology & Otology 3
Fig. 2. Distribution of H pylori positive results in the biopsy material of removed nasal
polyps or normal nasal mucosa (n = 75). There was a statistically significant difference
between the groups ( p < 0.05).
Table 1. Characteristics of H pylori positive and negative patients Table 2. Correlations between H pylori infection in nasal tissue and patients’
laryngopharyngeal reflux related data*
H pylori H pylori
Variable positive* negative† p Correlation
Variable co-efficient (r)† p
Males/females (%) 50.0/50.0 75.4/24.6 0.06
Laryngopharyngeal reflux related
Average age (years) 49.5 47.4 0.66 symptoms
Average BMI (kg/m2) 29.0 27.3 0.60 – Hoarseness 0.02 0.83
Smokers (%) 35.7 26.2 0.44 – Throat clearing 0.03 0.78
Drinkers (%) 35.7 45.9 0.29 – Excess throat mucus 0.06 0.61
History of GERD (%) 35.7 23.0 0.32 – Difficulty in food swallowing −0.07 0.55
Patients with pathological 57.1 41.0 0.27 – Coughing after eating or after 0.005 0.96
reflux symptom index (%) lying down
Patients with pathological 64.3 54.1 0.48 – Choking episodes 0.07 0.54
reflux finding score (%)
– Troublesome cough 0.15 0.18
*Patients with identified nasal H pylori (n = 14); †patients with unidentified nasal H pylori
(n = 61). BMI = body mass index; GERD = gastroesophageal reflux disease – Lump in throat 0.08 0.45
– Heartburn, chest pain, indigestion 0.07 0.54
or regurgitation
modify the mucosa of the nose and maxillary sinus as well. Laryngopharyngeal reflux related
signs
Such modifications may not only facilitate colonisation by H
pylori, but could also provide a target for an antibody – Subglottic oedema −0.11 0.34
response.10,23 – Ventricular obliteration −0.12 0.28
In 2003, Morinaka et al. established that H pylori may play – Erythema −0.10 0.38
a role as an antigen in patients who have chronic sinusitis with
infiltration of eosinophils and neutrophils.10 Similar data are – Vocal fold oedema −0.005 0.96
also available in the recent Bansal et al. study.11 The authors – Diffuse laryngeal oedema 0.02 0.82
examined samples from 35 nasal polyposis patients and 35 – Posterior commissure hypertrophy 0.24 0.04‡
controls with normal nasal mucosa, and assessed the morpho-
– Granuloma −0.08 0.49
logical changes. They found that inflammatory symptoms –
lymphocyte infiltration forming lymphocyte aggregates and – Thick endolaryngeal mucus −0.11 0.35
epithelial hyperplasia – were significantly more frequent in †
*n = 75. Pearson’s correlation co-efficient was used for parametric data and Spearman’s for
H pylori positive samples from nasal polyps than in samples non-parametric data. ‡Statistically significant ( p < 0.05)
Downloaded from https://www.cambridge.org/core. IP address: 78.63.210.201, on 04 Aug 2018 at 12:43:07, subject to the Cambridge Core terms of use, available at
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0022215118001299
6 N Siupsinskiene, I Katutiene, V Jonikiene et al.
19 Noorbakhsh S, Tabatabaei A, Farhadi M, Shamshiri AR. Helicobacter cagA in nasal polyps and laryngeal disorders. Otolaryngol Head Neck
pylori-DNA in nasal polyp tissues in compare with inferior nasal turbinate Surg 2009;141:131–5
tissues: a case-control study in Tehran, Iran. J Infect Dis Immun 25 Dinis PB, Subtil J. Helicobacter pylori and laryngopharyngeal reflux in
2011;3:73–8 chronic rhinosinusitis. Otolaryngol Head Neck Surg 2006;134:67–72
20 Burduk PK, Kaczmarek A, Budzynska A, Kazmierczak W, Gospodarek E. 26 Sella GC, Tamashiro E, Anselmo-Lima WT, Valera FC. Relation between
Detection of Helicobacter pylori and cagA gene in nasal polyps and benign chronic rhinosinusitis and gastroesophageal reflux in adults: systematic
laryngeal diseases. Arch Med Res 2011;42:686–9 review. Braz J Otorhinolaryngol 2017;83:356–63
21 Nikakhlagh S, Samarbafzadeh AR, Jahani M, Poostchi H, Kayedani GA, 27 Wong IW, Omari TI, Myers JC, Rees G, Nair SB, Jamieson GG et al.
Naghashpoor M et al. Determining the role of Helicobacter pylori in chronic Nasopharyngeal pH monitoring in chronic sinusitis patients using a
sinus infections using the polymerase chain reaction. Jundishapur J novel four channel probe. Laryngoscope 2004;114:1582–5
Microbiol 2015;8:e20783 28 Campbell R, Kilty SJ, Hutton B, Bonaparte JP. The role of Helicobacter
22 Jelavic B, Grgić M, Cupić H, Kordić M, Vasilj M, Baudoin T. Prognostic pylori in laryngopharyngeal reflux. Otolaryngol Head Neck Surg
value of Helicobacter pylori sinonasal colonization for efficacy of endo- 2017;156:255–62
scopic sinus surgery. Eur Arch Otorhinolaryngol 2012;269:2197–202 29 DelGaudio JM. Direct nasopharyngeal reflux of gastric acid is a contributing
23 Rook GA. The changing microbial environment and chronic inflammatory factor in refractory chronic rhinosinusitis. Laryngoscope 2005;115:946–57
disorders. Allergy Asthma Clin Immunol 2008;4:117–24 30 Nemati S, Mojtahedi A, Naghavi SE, Banan R, Zia F. Investigating
24 Ozyurt M, Gungor A, Ergunay K, Cekin E, Erkul E, Haznedaroglu T. Helicobacter pylori in nasal polyposis using polymerase chain reaction,
Real-time PCR detection of Helicobacter pylori and virulence-associated urease test and culture. Eur Arch Otorhinolaryngol 2012;269:1457–61
Downloaded from https://www.cambridge.org/core. IP address: 78.63.210.201, on 04 Aug 2018 at 12:43:07, subject to the Cambridge Core terms of use, available at
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0022215118001299
View publication stats